Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA
Phase 1
- Conditions
- Diabetic Peripheral Neuropathic Pain
- Interventions
- Drug: PlaceboDrug: CBD/PEA
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2023-03-13
- Lead Sponsor
- Pure Green Pharmaceuticals Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT05766969
- Locations
- 🇺🇸
Pure Green Pharmaceuticals Inc., Southfield, Michigan, United States
© Copyright 2025. All Rights Reserved by MedPath